Skyclarys Interactions
There are 459 drugs known to interact with Skyclarys (omaveloxolone), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 10 are major, 447 are moderate, and 2 are minor.
- View all 459 medications that may interact with Skyclarys
- View Skyclarys alcohol/food interactions (1)
- View Skyclarys disease interactions (1)
Most frequently checked interactions
View interaction reports for Skyclarys (omaveloxolone) and the medicines listed below.
- acetaminophen
- acetazolamide
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- alemtuzumab
- almotriptan
- amantadine
- Ambien (zolpidem)
- amitriptyline
- Amrix (cyclobenzaprine)
- Andexxa (coagulation factor Xa)
- aripiprazole
- Aspirin Low Strength (aspirin)
- atogepant
- atorvastatin
- azathioprine
- duloxetine
- escitalopram
- esomeprazole
- famotidine
- glatiramer
- Lyrica (pregabalin)
- propranolol
- Ubrelvy (ubrogepant)
- venlafaxine
- Vitamin D3 (cholecalciferol)
- Zetia (ezetimibe)
- Zyrtec (cetirizine)
Skyclarys alcohol/food interactions
There is 1 alcohol/food interaction with Skyclarys (omaveloxolone).
Skyclarys disease interactions
There is 1 disease interaction with Skyclarys (omaveloxolone) which include:
Report options
QR code containing a link to this page
More about Skyclarys (omaveloxolone)
- Skyclarys consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
